Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Our aim is to understand the specific mechanisms that give rise to SCRD in neuropsychiatric disease. Our laboratory-based team of circadian and sleep biologists, behavioural scientists and pharmacologists will address this issue by characterising the genetic, cellular, anatomical and physiological mechanisms underlying SCRD.

By understanding how these processes correspond to those involved in neuropsychiatric disease we can begin to develop new treatments for these conditions. We are working closely with clinical researchers to ensure our findings can be translated effectively from laboratory to clinic, providing new drugs and treatments for SCRD and neuropsychiatric illness.

Our team